annual CFO:
-$73.19M-$11.92M(-19.46%)Summary
- As of today (July 11, 2025), ELVN annual cash flow from operations is -$73.19 million, with the most recent change of -$11.92 million (-19.46%) on December 31, 2024.
- During the last 3 years, ELVN annual CFO has fallen by -$54.06 million (-282.52%).
- ELVN annual CFO is now -758.15% below its all-time high of -$8.53 million, reached on December 1, 2020.
Performance
ELVN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$24.13M-$6.92M(-40.25%)Summary
- As of today (July 11, 2025), ELVN quarterly cash flow from operations is -$24.13 million, with the most recent change of -$6.92 million (-40.25%) on March 31, 2025.
- Over the past year, ELVN quarterly CFO has dropped by -$766.00 thousand (-3.28%).
- ELVN quarterly CFO is now -274.24% below its all-time high of -$6.45 million, reached on September 30, 2022.
Performance
ELVN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$73.96M-$766.00K(-1.05%)Summary
- As of today (July 11, 2025), ELVN TTM cash flow from operations is -$73.96 million, with the most recent change of -$766.00 thousand (-1.05%) on March 31, 2025.
- Over the past year, ELVN TTM CFO has dropped by -$10.17 million (-15.95%).
- ELVN TTM CFO is now -613.81% below its all-time high of -$10.36 million, reached on March 1, 2022.
Performance
ELVN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ELVN Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.5% | -3.3% | -15.9% |
| 3 y3 years | -282.5% | -132.9% | -613.8% |
| 5 y5 years | -758.1% | - | - |
ELVN Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -282.5% | at low | -274.2% | at low | -323.0% | at low |
| 5 y | 5-year | -758.1% | at low | -274.2% | at low | -613.8% | at low |
| alltime | all time | -758.1% | at low | -274.2% | at low | -613.8% | at low |
ELVN Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$24.13M(+40.2%) | -$73.96M(+1.0%) |
| Dec 2024 | -$73.19M(+19.5%) | -$17.20M(+41.1%) | -$73.19M(+6.9%) |
| Sep 2024 | - | -$12.19M(-40.3%) | -$68.47M(-5.1%) |
| Jun 2024 | - | -$20.43M(-12.5%) | -$72.17M(+13.1%) |
| Mar 2024 | - | -$23.36M(+87.2%) | -$63.79M(+4.1%) |
| Dec 2023 | -$61.27M | -$12.48M(-21.5%) | -$61.27M(+7.6%) |
| Sep 2023 | - | -$15.89M(+31.9%) | -$56.93M(+19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$12.05M(-42.2%) | -$47.48M(+11.6%) |
| Mar 2023 | - | -$20.84M(+155.9%) | -$42.56M(+32.7%) |
| Dec 2022 | -$32.08M(+67.6%) | -$8.14M(+26.3%) | -$32.08M(+34.0%) |
| Sep 2022 | - | -$6.45M(-9.5%) | -$23.93M(+36.9%) |
| Jun 2022 | - | -$7.12M(-31.2%) | -$17.48M(+68.8%) |
| Mar 2022 | - | -$10.36M | -$10.36M |
| Dec 2021 | -$19.13M(+124.3%) | - | - |
| Dec 2020 | -$8.53M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual CFO year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Enliven Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM CFO year-on-year change?
What is Enliven Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of ELVN is -$73.19M
What is the all time high annual CFO for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual cash flow from operations is -$8.53M
What is Enliven Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, ELVN annual cash flow from operations has changed by -$11.92M (-19.46%)
What is Enliven Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of ELVN is -$24.13M
What is the all time high quarterly CFO for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly cash flow from operations is -$6.45M
What is Enliven Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, ELVN quarterly cash flow from operations has changed by -$766.00K (-3.28%)
What is Enliven Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of ELVN is -$73.96M
What is the all time high TTM CFO for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM cash flow from operations is -$10.36M
What is Enliven Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, ELVN TTM cash flow from operations has changed by -$10.17M (-15.95%)